Wells Fargo Upgrades Sutro Biopharma (STRO) to Overweight

March 24, 2026 4:05 AM

Wells Fargo analyst Eva Fortea-Verdejo upgraded Sutro Biopharma (NASDAQ: STRO) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found